Skip to main content
Caplight Logo









TransAlgae

TransAlgae

Private
IsraelHealthcare & Life Scienceshttps://transalgae.com/

Last Round

Early Funding

Apr 1, 2021

Total Funding Raised

$13.06M

Company Overview

TransAlgae is a biotechnology company that has developed a platform for the oral delivery of drugs, vaccines, and pesticides using genetically modified algae for the animal health and crop protection industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

oral delivery platformalgae production systemgenetically modified algaeoral vaccinesbiopesticidesRNAi technologyaquaculture vaccinesagtechcrop protectionanimal healthbio-encapsulationfeed additiveRNA interferenceRNAitechnology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TransAlgae Comparables

Compare TransAlgae with similar companies based on industry and business-model similarity.

TransAlgae comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ViAqua Therapeutics
79%
FeedVax
79%
Sundew Bio
76%

TransAlgae Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 1, 2021

Key People

Founding team and executive leadership

Maor Sasson

CEO

Executive Team

Ofra Chen

Deputy CEO & CTO At TransAlgae

Executive Team

Zohar Rotem

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2021

    $2.5M raised with Gan Shmuel Foods Ltd. as lead investor.

TransAlgae Filings

Explore SEC and related filing metadata, where available.

TransAlgae filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TransAlgae's valuation, stock price, and market status.

Is TransAlgae a public or private company?

TransAlgae is a private company.

What is the current stock price of TransAlgae?

TransAlgae is a private company with no public stock price. No recent secondary market data is available.

How much is TransAlgae worth (valuation)?

Valuation information for TransAlgae is not publicly available.

Can I buy TransAlgae stock?

TransAlgae shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TransAlgae's last funding round?

Funding round information for TransAlgae is not publicly available.

Who are the main investors in TransAlgae?

Investor information for TransAlgae is not publicly disclosed.

Will TransAlgae IPO soon?

No public IPO plans have been announced for TransAlgae.

How can I track TransAlgae secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TransAlgae's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range10
Year Founded2008
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?